News Conference News AHA 2018 Novel Inhibitor of Apolipoprotein(a) Production Lowers Lp(a) in Phase II Study Shelley Wood November 11, 2018
News Daily News Elevated Lp(a), Even in Statin-Treated Patients, Linked With Higher CVD Risks Michael O'Riordan October 15, 2018
News Daily News Hemodynamic Deterioration Post-SAVR: Dysmetabolic Profile, Calcification Could Be Early Warning Signs Caitlin E. Cox July 10, 2018
News Daily News Lp(a) Might Not Be Good at Predicting Incident CVD in Low-Risk Women Yael L. Maxwell July 09, 2018
News Daily News Clinical Benefit of Lowering Lp(a) Is Proportional to Its Absolute Reduction: Mendelian Randomization Analysis Yael L. Maxwell June 25, 2018
News Conference News EAS 2018 ORION 1 Data Show Lipoprotein-Lowering Beyond LDL Cholesterol With Injectable Inclisiran Yael L. Maxwell May 14, 2018
News Conference News EAS 2018 Unlocking Lp(a): Baseline Levels Matter, but So Too Does Absolute Reduction Yael L. Maxwell May 08, 2018
News Conference News EAS 2018 Can Clinicians Really Put a Stop to Atherosclerosis? Experts Explore the How and When of CVD Prevention Yael L. Maxwell May 07, 2018
Presentation EAS 2018 LPA variants, risk of coronary disease, and estimated clinical benefit of lipoprotein(a) lowering therapies: a Mendelian randomization analysis Presenter: Brian A. Ference May 07, 2018
News Daily News LPA Variants Linked With CHD Events in Statin-Treated Patients Michael O'Riordan May 03, 2018
News Daily News Role of Lp(a) Still to Be Determined, but NHLBI Sees a Path Forward Michael O'Riordan January 09, 2018